SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-015808
Filing Date
2023-04-03
Accepted
2023-04-03 16:32:08
Documents
6
Period of Report
2023-05-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20007623x2_def14a.htm DEF 14A 945978
2 logo_cyclerion-c.jpg GRAPHIC 30148
3 ny20007623x2_pc01.jpg GRAPHIC 766820
4 ny20007623x2_pc02.jpg GRAPHIC 465375
5 sig_agjino.jpg GRAPHIC 13887
6 sig_pmhecht.jpg GRAPHIC 17805
  Complete submission text file 0001140361-23-015808.txt   2727936
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38787 | Film No.: 23793195
SIC: 2834 Pharmaceutical Preparations